about
Nanoparticle ligand presentation for targeting solid tumorsCancer nanotechnology: emerging role of gold nanoconjugatesLong circulating lectin conjugated paclitaxel loaded magnetic nanoparticles: a new theranostic avenue for leukemia therapyFolate decorated dual drug loaded nanoparticle: role of curcumin in enhancing therapeutic potential of nutlin-3a by reversing multidrug resistanceThe use of sensitive chemical antibodies for diagnosis: detection of low levels of EpCAM in breast cancerPreparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation.RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule.Enhanced anti-metastatic and anti-tumorigenic efficacy of Berbamine loaded lipid nanoparticles in vivo.Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugsBioengineering strategies for designing targeted cancer therapiesTargeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid TumorsHigh resolution fluorescence imaging of cancers using lanthanide ion-doped upconverting nanocrystals.Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention.Development of cytarabine prodrugs and delivery systems for leukemia treatment.Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics.Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies.Recent advances in ligand targeted therapy.Micelle-like nanoassemblies based on polymer-drug conjugates as an emerging platform for drug delivery.Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.Gold nanoparticles in theranostic oncology: current state-of-the-art.Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.Guiding principles in the design of ligand-targeted nanomedicines.Antibody-targeted biodegradable nanoparticles for cancer therapy.Folate-conjugated gold nanoparticle as a new nanoplatform for targeted cancer therapy.Targeted nutlin-3a loaded nanoparticles inhibiting p53-MDM2 interaction: novel strategy for breast cancer therapy.Novel biotinylated bile acid amphiphiles: micellar aggregates formation and interaction with hepatocytes.Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier.Enhanced antiproliferative activity of antibody-functionalized polymeric nanoparticles for targeted delivery of anti-miR-21 to HER2 positive gastric cancer.Solid-phase supported design of carriers for therapeutic nucleic acid delivery.Poly(lactic-co-glycolic acid) nanoparticles for sustained release of allyl isothiocyanate: characterization, in vitro release and biological activity.Insights into DNA Platination within Unusual Structural SettingsSelective depletion of metastatic stem cells as therapy for human colorectal cancerModulatory Effect of Citrate Reduced Gold and Biosynthesized Silver Nanoparticles on α-Amylase Activity
P2860
Q27009522-59DAD428-520B-4B0E-A230-68C2D1CDFD88Q27021820-B4C2D03F-335D-4179-91A4-057566478900Q28477996-9A5AED4E-165C-4073-9870-362B819554D8Q28481616-B4D78958-8FAB-4926-ABE5-B8E3E60F57CEQ28486906-CEF424D9-F9F0-41D2-A50A-09F277AB0139Q33599486-38015314-28DF-4240-87E6-BB1EA2757423Q33807710-0B4A1B0C-770B-4BFC-B128-5A48169BE13AQ33918405-B88E7070-DAB6-497F-81D7-52F4A6D2323FQ33997393-BF5012BA-B753-4D90-88A1-2C86A011BD04Q34194191-D4D786D0-1FE6-4C60-9E66-EFA6D9A96EB9Q34763617-A52F62E6-20AD-423E-B247-8CADC401AF07Q35868868-B2A16288-0E4A-4FA4-A8E0-38355F1DA937Q37017124-156FEF53-6EA0-4901-A82C-F267539D5BC2Q37727325-70AF2A69-7114-49B8-8FB3-A4074B8DCB73Q37801934-36BE8C29-DE21-4054-8988-55A3A382B21AQ37885883-F75CCD9C-DD10-4325-89FE-5273BA571E0DQ37910273-DF79CAF1-5CCD-42B3-AA03-B0E9BCC5345AQ37937611-B7376A46-4DC7-4041-BE10-8F6009F003BAQ38011258-8E0F476C-6954-4E30-8DB5-23F1AD827DB0Q38034167-6E3667E6-07B8-47C0-863E-F854EAD11204Q38035034-7501C62C-F673-4705-BC0E-F4ED39E8420EQ38042744-26E49E9C-5314-450A-ACCB-747685740EA6Q38189490-B904B327-CA2D-4B17-9D77-87B3F10FC527Q38665261-0E1FC162-E09B-460F-9D59-A7F069CD0BD0Q38840971-21DFDBC3-1204-4439-8858-F1D7D3BF331DQ39548243-5325FED9-080C-46F1-B5C6-986CF6C70A96Q39581711-AFD35324-694D-49A3-87BB-524751B8047EQ39819856-232FE2C2-D014-4A43-AD40-AF5C34FAC6D6Q42366537-E30602E6-2129-47A0-BDF7-EA3C98A08104Q42921833-65583956-2D07-4B16-B806-64FFC07811EDQ48223276-62C72B79-C82D-4C7F-96A8-506E990A8BDBQ58687548-16244E5C-E1F6-4801-AFBA-1669326BC65DQ58760599-4E4CF40E-CB33-49EC-914C-B93124E53D55Q59114125-0D4708FA-C410-494A-89FE-5F5CF6451DC1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ligand-based targeted therapy for cancer tissue.
@en
Ligand-based targeted therapy for cancer tissue.
@nl
type
label
Ligand-based targeted therapy for cancer tissue.
@en
Ligand-based targeted therapy for cancer tissue.
@nl
prefLabel
Ligand-based targeted therapy for cancer tissue.
@en
Ligand-based targeted therapy for cancer tissue.
@nl
P2093
P2860
P1476
Ligand-based targeted therapy for cancer tissue.
@en
P2093
Chandana Mohanty
Manasi Das
Sanjeeb K Sahoo
P2860
P304
P356
10.1517/17425240902780166
P407
P577
2009-03-01T00:00:00Z